CIPROAGE: Citrulline and Protein Metabolism in the Malnourished Elderly People

Sponsor
Assistance Publique - Hôpitaux de Paris (Other)
Overall Status
Completed
CT.gov ID
NCT00714675
Collaborator
Kyowa Hakko Kogyo (Japan) providing the amino acids (Other)
27
1
2
37
0.7

Study Details

Study Description

Brief Summary

The aim of this study is to evaluate the effects of a supplementation of citrulline for three weeks in elderly malnourished and hospitalised subjects on muscle protein synthesis.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Citrulline
  • Dietary Supplement: Amino acids
N/A

Detailed Description

Malnutrition in the elderly causes an important public health problem because their response to re nutrition is highly decreased. Several experimental studies have shown that an amino acid named citrulline could avoid this, by restoring protein synthesis.

The treated group will receive each morning for three weeks a supplementation of 10 g of citrulline and the control group, non essential amino acids in iso-nitrogenous quantity to the 10g of citrulline.

During the three weeks of supplementation, clinical tolerance and physical exercise will be evaluated regularly.

On the 21st day, whole body protein synthesis rate in the post-absorptive state will be measured by the isotopic dilution of L-leucine (1-13C expressed in g / kg of lean mass / 24h) as well as other parameters of the protein turn-over in the post-absorptive and post-prandial state.

Study Design

Study Type:
Interventional
Actual Enrollment :
27 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Investigator)
Primary Purpose:
Treatment
Official Title:
Citrulline Supplementation in Elderly Malnourished and Hospitalised Subjects: Effects on Protein Metabolism
Study Start Date :
Dec 1, 2009
Actual Primary Completion Date :
Jan 1, 2013
Actual Study Completion Date :
Jan 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

Citrulline

Dietary Supplement: Citrulline
1 unit of 10 g L-Citrulline, 1 time on morning during 21 days

Active Comparator: 2

Amino acids

Dietary Supplement: Amino acids
1 unit of an equivalent quantity of iso nitrogenous of non-essential amino acids(alanine, aspartate, glycine, serine, histidine, proline), 1 time on morning during 21 days.

Outcome Measures

Primary Outcome Measures

  1. Whole body protein synthesis rate in the post-absorptive state measured by the isotopic dilution of L-leucine (1-13C expressed in g / kg of lean mass / 24h) [after 3 weeks of treatment]

Secondary Outcome Measures

  1. clinical tolerance [Every day]

Eligibility Criteria

Criteria

Ages Eligible for Study:
70 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • elderly hospitalised in geriatric medicine or in following care and rehabilitation, moderately malnourished

  • aged more than 70 years

  • recent moderate undernutrition (30 g/l < albuminemia < 35 g/l and 18 < BMI < 22 or a score of the Mini Nutritional Assessment (MNA) < 17 with albuminemia > 30 g/l)

  • ingesta of at least 20 kcal / kg / d and 0,8 g / kg / d of proteins

Exclusion Criteria:
  • hospitalisation < 21d

  • C reactive protein (CRP) > 50 mg / l

  • end-stage cardiac insufficiency

  • severe digestive incapacity

  • renal insufficiency (Creatinine Clearance < 30 ml / mn)

  • respiratory failure

  • MMS < 18

  • uncontrolled acute or chronic infectious pathology (HIV, tuberculosis)

  • corticoids treatment

  • evolutionary neoplasia

  • palliative phase of severe pathology

  • Mental Mini Score status of Folstein (MMS) < 8

  • parenteral nutrition

  • active chronic hepatitis or cirrhosis

  • participation in another trial

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hôpital Emile Roux Limeil-Brevannes France 94

Sponsors and Collaborators

  • Assistance Publique - Hôpitaux de Paris
  • Kyowa Hakko Kogyo (Japan) providing the amino acids

Investigators

  • Principal Investigator: Jean-Claude Melchior, Assistance Publique - Hôpitaux de Paris

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT00714675
Other Study ID Numbers:
  • P070127
First Posted:
Jul 14, 2008
Last Update Posted:
Dec 31, 2013
Last Verified:
Dec 1, 2013
Keywords provided by Assistance Publique - Hôpitaux de Paris
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 31, 2013